Schrodinger

SDGR Small Cap

Healthcare · Health Information Services

Updated: Apr 5, 2026, 17:43 UTC

$11.58

+0.26% today

52W: $10.95 – $27.63

52W Low: $10.95 Position: 3.8% 52W High: $27.63

🔗 Compare Brokers

Key Metrics

P/E Ratio

—

Price-to-Earnings

Forward P/E

—

Forward Price/Earnings

P/S Ratio

3.34x

Price-to-Sales

EV/EBITDA

—

Enterprise Value/EBITDA

Div. Yield

—

Annual dividend yield

Market Cap

$854.9M

Market Capitalization

Revenue Growth

-1.2%

YoY Revenue Growth

Profit Margin

-40.36%

Net profit margin

ROE

-26.29%

Return on Equity

Beta

1.62

Market sensitivity

Short Interest

27.87%

% of float sold short

Avg. Volume

1,355,975

Average daily volume

Valuation Analysis

Signal

N/A

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Strong Buy

8 analysts

Avg. Price Target

$22.00

+89.98% upside

Target Range

$13.00 – $30.00

About the Company

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New

Sector: Healthcare Industry: Health Information Services Country: United States Employees: 850 Exchange: NMS